Search

everythinglearnresearchcommunity

for

Search:↓

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

The treatment helped regrow hair in women with hair loss.

Houttuynia cordata extract may help hair grow by improving cell survival and increasing cell growth.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Mutations in the DSG4 gene cause fragile, sparse hair in humans, mice, and rats.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

A new CDH3 gene mutation was found in a Spanish patient with sparse hair and eye issues.

Hutchinson-Gilford Progeria Syndrome causes rapid aging due to a gene mutation, with no cure yet, but research may lead to better treatments.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Suppressing the HGPS mutation may improve symptoms and suggest reversibility.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Polynucleotides HPT improves Asian skin tone, firmness, and glow safely.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

HS needs personalized treatment plans and more research.

PGD2 stops hair growth and is higher in bald men with AGA.

Deleting podoplanin in mice promotes hair growth by enhancing cell migration.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Hairless protein can block vitamin D activation in skin cells.

To improve use of the contraceptive DMPA among adolescents, effectively manage side effects like menstrual changes and weight gain through counseling and guidance.

Hsc70 protein may influence hair growth by responding to androgens.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.